Q&A: Sage Launches Open Access Bionetwork Platform to Kickstart Drug Discovery
March 06, 2009
Q&A: Sage Launches Open Access Bionetwork Platform to Kickstart Drug Discovery
Merck's Eric Schadt discusses Sage, a new nonprofit that aims to build an open-access research platform to integrate human biological networks, predictive computational network models, and annotated information on human disease
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Philips Research Plans Clinical Study for Software to Help Oncologists Interpret NGS Data
May 17, 2013 / BioInform - InSilico Genomics to Use $1.5M in Seed Money to Improve Bioinformatics Infrastructure
May 17, 2013 / BioInform - Q&A: BU Scientists Discuss Informatics Education Needs for Translational Researchers
May 17, 2013 / BioInform - System Biosciences Taps Maverix's Platform for Exosome Sequence Analytics Service
May 17, 2013 / BioInform - Belgium's VIB Licenses Biogazelle's Qbase+ for PCR Data Analysis
May 17, 2013 / BioInform